|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 99, 889-895, Copyright © 1990 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
DB Doty, JR Doty and KW Jones
Nine patients had operations for obstruction of the superior vena cava with
superior vena caval syndrome caused by benign disease. Three patients had
fibrosing mediastinitis, four had fibrosing mediastinitis with caseous
necrosis, one had thrombosis of the superior vena cava around a pacemaker
electrode, and one had spontaneous thrombosis of the superior vena cava.
Patients ranged in age from 25 to 68 years. All bypass operations were
performed with a composite spiral vein graft constructed from the patient's
own saphenous vein, split longitudinally and wrapped around a stent in
spiral fashion. The edges of the vein were sutured together to form a large
conduit ranging in diameter from 9.5 to 15.0 mm. Six grafts were from the
left innominate vein and three grafts were from the internal jugular vein.
The grafts were placed into the right atrial appendage in all except one
case, in which the graft was to the distal superior vena cava. Follow-up
extends from 1 to 15 years. One patient required reoperation at 4 days for
thrombosis at the innominate vein-graft anastomosis. Resection of the
anastomosis and reconstruction of the graft rendered the patient symptom
free. Two grafts closed during the first year after operation. One patient
had advancing fibrosing mediastinitis, and a second bypass graft from the
external jugular veins remain patent. Another patient had recurrence of
spontaneous venous thrombosis. Thus seven of nine grafts remain patent for
up to nearly 15 years and all but one patient is free of superior vena
caval syndrome. These data show that bypass of the obstructed superior vena
cava with a spiral vein graft relieves superior vena caval syndrome and
demonstrate long-term patency of the graft.
ARTICLES
Bypass of superior vena cava. Fifteen years' experience with spiral vein graft for obstruction of superior vena cava caused by benign disease
Department of Surgery, LDS Hospital, Salt Lake City, Utah.
This article has been cited by other articles:
![]() |
B. Mahesh and C. Ratnatunga Superior Vena Cava Reconstruction with Homograft Conduit under Circulatory Arrest Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 345 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bays, C. Rajakaruna, E. Sheffield, and A. Morgan Fibrosing mediastinitis as a cause of superior vena cava syndrome Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 453 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Terada, N. Ono, T. Noguchi, K. Kamakari, and M. Kitano A case of thymoma protruding into the superior vena cava through the thymic vein Ann. Thorac. Surg., March 1, 2004; 77(3): 1088 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Billing, C. D. Sudarshan, P. M. Schofield, F. Murgatroyd, and F. C. Wells Aortic arch homograft as a bypass conduit for superior vena cava obstruction Ann. Thorac. Surg., October 1, 2003; 76(4): 1296 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Eguchi, K. Kobayashi, I. Hasegawa, and S. Nakatsuka Restenosis of superior vena cava after treatment using a self-expanding metallic stent in a patient with idiopathic fibrosing mediastinitis Interactive CardioVascular and Thoracic Surgery, September 1, 2003; 2(3): 355 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lanciego, J. L. Chacon, A. Julian, J. Andrade, L. Lopez, B. Martinez, M. Cruz, and L. Garcia-Garcia Stenting as First Option for Endovascular Treatment of Malignant Superior Vena Cava Syndrome Am. J. Roentgenol., September 1, 2001; 177(3): 585 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Molina Use of Cryopreserved Small Aortic Homografts for Large Vein Replacement Vascular and Endovascular Surgery, September 1, 1999; 33(5): 545 - 555. [Abstract] [PDF] |
||||
![]() |
J. R. Roberts, R. Bueno, and D. J. Sugarbaker Multimodality Treatment of Malignant Superior Vena Caval Syndrome Chest, September 1, 1999; 116(3): 835 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Aleksic, F. Saldana, T. Busch, D. Basenau, H. Sirbu, A. Schauer, and H. Dalichau Unsuspected idiopathic mediastinal fibrosis complicating coronary bypass operation Ann. Thorac. Surg., January 1, 1999; 67(1): 224 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Narayan, L. Brown, and J. O. Thayer Surgical management of superior vena caval syndrome in sarcoidosis Ann. Thorac. Surg., September 1, 1998; 66(3): 946 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shah, S. Sabanathan, R. A. Lowe, and A. J. Mearns STENTING IN MALIGNANT OBSTRUCTION OF SUPERIOR VENA CAVA J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 335 - 340. [Abstract] [Full Text] |
||||
![]() |
R. Y. Rhee, P. Gloviczki, J. L. Steers, R. A. F. Krom, K. Kitabayashi, and R. H. Wiesner Superior Vena Cava Reconstruction Using An Iliocaval Allograft: A Case Report Vascular and Endovascular Surgery, January 1, 1996; 30(1): 77 - 83. [Abstract] [PDF] |
||||
![]() |
J. M. Levett, W. G. Meffert, W. W. Strong, A. C. Hass, R. A. Macke, G. G. Berg, M. A. Nelson, and C. Ghosh Leiomyosarcoma of the Superior Vena Cava and Azygos Vein Ann. Thorac. Surg., November 1, 1995; 60(5): 1415 - 1417. [Abstract] [Full Text] |
||||
![]() |
J. A. Gonzalez-Fajardo, M. Garcia-Yuste, S. Florez, G. Ramos, T. Alvarez, and J. M. Coca Hemodynamic and cerebral repercussions arising from surgical interruption of the superior vena cavaExperimental model J. Thorac. Cardiovasc. Surg., April 1, 1994; 107(4): 1044 - 1049. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |